Diametric Capital, LP Catalyst Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

  • $173 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$11.78 - $17.29 $170,939 - $250,895
-14,511 Reduced 45.56%
17,336 $291,000
Q3 2023

Nov 14, 2023
BUY
$11.69 - $15.02 $372,291 - $478,341
31,847 New
31,847 $372,000
Q3 2019

Nov 13, 2019
SELL
$3.89 - $7.43 $197,055 - $376,381
-50,657 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$2.7 - $6.11 $136,773 - $309,514
50,657 New
50,657 $195,000

Others Institutions Holding CPRX

# of Institutions
327
Shares Held
94.1M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.33B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email